FATE – Fate Therapeutics, Inc.
FATE — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.62
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
EPS Last/This Y
0.11
EPS This/Next Y
0.05
Price
2.8
Target Price
5.41
Analyst Recom
2
Performance Q
15.23
Upside
-606.1%
Beta
2.55
Ticker: FATE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | FATE | 3.02 | 0.28 | 0.08 | 7548 |
| 2026-07-14 | FATE | 2.98 | 0.27 | 0.61 | 7589 |
| 2026-07-15 | FATE | 2.98 | 0.27 | 0.00 | 7620 |
| 2026-07-16 | FATE | 2.72 | 0.27 | 0.06 | 7619 |
| 2026-07-17 | FATE | 2.78 | 0.27 | 0.15 | 7621 |
| 2026-07-20 | FATE | 2.8 | 0.21 | 0.03 | 5883 |
| 2026-07-21 | FATE | 2.84 | 0.21 | 0.00 | 6065 |
| 2026-07-22 | FATE | 2.57 | 0.21 | 0.13 | 6070 |
| 2026-07-23 | FATE | 2.52 | 0.20 | 0.07 | 6210 |
| 2026-07-24 | FATE | 2.41 | 0.21 | 0.86 | 6240 |
| 2026-07-27 | FATE | 2.42 | 0.21 | 0.00 | 6265 |
| 2026-07-28 | FATE | 2.32 | 0.21 | 0.12 | 6258 |
| 2026-07-29 | FATE | 2.37 | 0.20 | 0.00 | 6405 |
| 2026-07-30 | FATE | 2.51 | 0.20 | 0.00 | 6469 |
| 2026-07-31 | FATE | 2.44 | 0.20 | 0.00 | 6477 |
| 2026-08-03 | FATE | 2.48 | 0.20 | 1.67 | 6478 |
| 2026-08-04 | FATE | 2.57 | 0.21 | 0.15 | 6530 |
| 2026-08-05 | FATE | 2.59 | 0.20 | 0.02 | 6562 |
| 2026-08-06 | FATE | 2.48 | 0.20 | 0.00 | 6851 |
| 2026-08-07 | FATE | 2.8 | 0.20 | 0.01 | 6851 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | FATE | 3.01 | 11.5 | - | -1.03 |
| 2026-07-14 | FATE | 2.98 | 11.5 | - | -1.03 |
| 2026-07-15 | FATE | 2.98 | 11.5 | - | -1.03 |
| 2026-07-16 | FATE | 2.72 | 11.5 | - | -1.03 |
| 2026-07-17 | FATE | 2.78 | 11.5 | - | -1.04 |
| 2026-07-20 | FATE | 2.80 | 11.5 | - | -1.04 |
| 2026-07-21 | FATE | 2.84 | 11.5 | - | -1.04 |
| 2026-07-22 | FATE | 2.57 | 11.5 | - | -1.04 |
| 2026-07-23 | FATE | 2.52 | 11.5 | - | -1.04 |
| 2026-07-24 | FATE | 2.41 | 11.5 | - | -1.04 |
| 2026-07-27 | FATE | 2.43 | 11.5 | - | -1.04 |
| 2026-07-28 | FATE | 2.32 | 11.5 | - | -1.04 |
| 2026-07-29 | FATE | 2.36 | 11.5 | - | -1.04 |
| 2026-07-30 | FATE | 2.51 | 11.5 | - | -1.04 |
| 2026-07-31 | FATE | 2.44 | 11.5 | - | -1.04 |
| 2026-08-03 | FATE | 2.48 | 11.5 | - | -1.04 |
| 2026-08-04 | FATE | 2.48 | 11.5 | - | -1.04 |
| 2026-08-05 | FATE | 2.58 | 11.5 | - | -1.04 |
| 2026-08-06 | FATE | 2.49 | 11.5 | - | -1.04 |
| 2026-08-07 | FATE | 2.80 | 11.5 | - | -1.04 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | FATE | -0.90 | 3.38 | 6.72 |
| 2026-07-14 | FATE | -0.90 | 3.38 | 6.72 |
| 2026-07-15 | FATE | -0.90 | 3.38 | 6.72 |
| 2026-07-16 | FATE | -0.90 | 3.38 | 6.72 |
| 2026-07-17 | FATE | -0.90 | 3.38 | 6.72 |
| 2026-07-20 | FATE | -0.90 | 3.45 | 6.72 |
| 2026-07-21 | FATE | -0.90 | 3.45 | 6.72 |
| 2026-07-22 | FATE | -0.90 | 3.45 | 6.72 |
| 2026-07-23 | FATE | -0.90 | 3.45 | 6.72 |
| 2026-07-24 | FATE | -0.90 | 3.45 | 6.72 |
| 2026-07-27 | FATE | -0.90 | 3.44 | 6.62 |
| 2026-07-28 | FATE | -0.90 | 3.44 | 6.62 |
| 2026-07-29 | FATE | -0.90 | 3.44 | 6.62 |
| 2026-07-30 | FATE | -0.90 | 3.44 | 6.62 |
| 2026-07-31 | FATE | -0.90 | 3.44 | 6.62 |
| 2026-08-03 | FATE | -0.90 | 3.52 | 6.62 |
| 2026-08-04 | FATE | -0.90 | 3.52 | 6.62 |
| 2026-08-05 | FATE | -2.23 | 3.52 | 6.62 |
| 2026-08-06 | FATE | -2.23 | 3.52 | 6.62 |
| 2026-08-07 | FATE | -2.23 | 3.52 | 6.62 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.26
Avg. EPS Est. Current Quarter
-0.26
Avg. EPS Est. Next Quarter
-0.26
Insider Transactions
-2.23
Institutional Transactions
3.52
Beta
2.55
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
13
Growth Score
24
Sentiment Score
56
Actual DrawDown %
97.1
Max Drawdown 5-Year %
-99.3
Target Price
5.41
P/E
Forward P/E
PEG
P/S
51.64
P/B
1.81
P/Free Cash Flow
EPS
-1.09
Average EPS Est. Cur. Y
-1.04
EPS Next Y. (Est.)
-0.99
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-2056.79
Relative Volume
1.04
Return on Equity vs Sector %
-99.6
Return on Equity vs Industry %
-83.5
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
◆
FATE
Healthcare
$2.80
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
58.5
Range 1M
54.6%
Sup Dist
13.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
5.9%
EPS NY
4.7%
52W%
80.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+93.2% upside
Upside
+93.2%
Quality
13
FATE — P/E HistoricalBiotechnology
Fate Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 161
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.
FATE
Latest News
—
Caricamento notizie per FATE…
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading